High Tower Advisors, LLC Moderna, Inc. Put Options Transaction History

High Tower Advisors, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $2.7 Million - $5.32 Million	42,500 New	42,500 $2.84 Million
Q4 2023 Feb 12, 2024	BUY	$69.51 - $104.43 $89,876 - $135,027	1,293 Added 18471.43%	1,300 $129,000
Q3 2023 Nov 08, 2023	SELL	$96.41 - $126.61 $96 - $126	-1 Reduced 12.5%	7 $0
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $22,752 - $30,821	-192 Reduced 96.0%	8 $0
Q1 2023 May 11, 2023	BUY	$135.66 - $197.02 $26,725 - $38,812	197 Added 6566.67%	200 $30,000
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $355 - $630	3 New	3 $0
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $23,308 - $35,141	199 Added 19900.0%	200 $1,000
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $1,011 - $1,880	-8 Reduced 88.89%	1 $0
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $178,623 - $291,491	-791 Reduced 98.88%	9 $115,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $177,076 - $386,607	798 Added 39900.0%	800 $39,000
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $131 - $339	2 New	2 $5,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.